# Phase 2 Anemia, Aplastic trials recruiting: 27 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 27 trials in phase 2 for Anemia, Aplastic that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 2 Anemia, Aplastic trials: 27 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-2/anemia-aplastic

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 27
- Recruiting or not yet: 27
- Read on: November 19, 2026

## Trials

The 25 newest of 27, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 21, 2026 | NCT07885982 | Conditioning Regimen Containing Low-Dose ATG for the Treatment of AA Receiving sUCBT | Anhui Provincial Hospital | Phase 2 | Not yet recruiting | Aplastic Anaemia | 59 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07885982) |
| July 13, 2026 | NCT07698080 | Dexamethasone, Intravenous Injection of Human Immunoglobulin, and Increased Infusion of Mononuclear Cells to Reduce Donor Specific... | Hematology department of the 920th hospital | Phase 2 | Not yet recruiting | Leukemia, Lymphoma, Thalassemia, Aplastic Anemia, Myelodysplastic Syndromes | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07698080) |
| May 7, 2026 | NCT07572084 | Romiplostim N01 in Chemoradiotherapy-induced Aplastic Anemia | Peking Union Medical College Hospital | Phase 2 | Not yet recruiting | Aplastic Anemia | 43 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07572084) |
| April 30, 2026 | NCT07558434 | CsA+EPAG/HPAG+Romiplostim N01 in Newly-diagnosed SAA/TD-NSAA | Peking Union Medical College Hospital | Phase 2 | Not yet recruiting | Severe Aplastic Anemia (SAA), Transfusion-dependent Non-severe Aplastic Anemia | 43 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07558434) |
| March 30, 2026 | NCT07499102 | CK0801 for Treatment of Aplastic Anemia | Cellenkos, Inc. | Phase 2 | Not yet recruiting | Aplastic Anemia | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07499102) |
| February 10, 2026 | NCT07400341 | Romiplostim Versus rhTPO for Platelet Engraftment After Transplant in MDS and AA | The First Affiliated Hospital of Soochow University | Phase 2 | Recruiting | MDS (Myelodysplastic Syndrome), Aplastic Anemia (AA) | 66 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07400341) |
| July 22, 2025 | NCT07078721 | Efficacy and Safety of UCBT With TMI -Based Conditioning Regimen for Adults With Refractory/Relapsed Aplastic Anemia | Institute of Hematology & Blood Diseases Hospital, China | Phase 2 | Not yet recruiting | Aplastic Anemia Idiopathic | 11 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07078721) |
| January 30, 2025 | NCT06802055 | Efficacy and Safety of Sirolimus With or Without Cyclosporin A in Chinese Patients With Aplastic Anemia Refractory/Intolerant to... | Peking Union Medical College Hospital | Phase 2 | Recruiting | Aplastic Anaemia | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06802055) |
| January 10, 2025 | NCT06769568 | Reduced-dose Conditioning Regimen Containing TBI in HSCT Treating Elderly Patients With Aplastic Anemia | Institute of Hematology & Blood Diseases Hospital, China | Phase 2 | Not yet recruiting | Aplastic Anaemia, HSCT, TBI, Old Age | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06769568) |
| October 17, 2024 | NCT06646497 | Indication of HSCT in Patients With Refractory/Relapse AA After First-line Standard Immunosuppressive Therapy Aged More Than 40 Years | Assistance Publique - Hôpitaux de Paris | Phase 2 | Recruiting | Aplastic Anemia | 52 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06646497) |
| July 24, 2024 | NCT06517641 | Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia | Medical College of Wisconsin | Phase 2 | Recruiting | Severe Aplastic Anemia | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06517641) |
| May 28, 2024 | NCT06430788 | A Study of Emapalumab for Pediatric Aplastic Anemia | Memorial Sloan Kettering Cancer Center | Phase 2 | Recruiting | Aplastic Anemia, Cytopenia, Hypocellular Marrow | 35 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06430788) |
| May 14, 2024 | NCT06412497 | MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic... | Masonic Cancer Center, University of Minnesota | Phase 2 | Recruiting | Severe Aplastic Anemia, Acquired Amegakaryocytic Thrombocytopenia, Acquired Pure Red Cell Aplasia, Paroxysmal Nocturnal... | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06412497) |
| April 22, 2024 | NCT06378060 | Clinical Study on Modified Allogeneic Hematopoietic Stem Cell Transplantation Regimen for Severe Aplastic Anemia | Hematology department of the 920th hospital | Phase 2 | Recruiting | Severe Aplastic Anemia | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06378060) |
| February 12, 2024 | NCT06254560 | Rituximab for Serious Aplastic Anemia With Platelet Transfusion Refractoriness | Institute of Hematology & Blood Diseases Hospital, China | Phase 2 | Recruiting | Severe Aplastic Anemia, Platelet Transfusion Refractoriness | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06254560) |
| June 15, 2022 | NCT05419843 | Up-front Matched Unrelated Donor Transplantation in Pediatric Patients With Idiopathic Aplastic Anemia | Assistance Publique - Hôpitaux de Paris | Phase 2 | Not yet recruiting | Idiopathic Aplastic Anemia, Severe Aplastic Anemia, Moderate Aplastic Anemia Requiring Transfusions | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05419843) |
| January 18, 2022 | NCT05194397 | Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors | Children's Hospital of Philadelphia | Phase 2 | Recruiting | Lymphoblastic Leukemia, Cancer Survivors, Aplastic Anemia, Myelodysplastic Syndromes, Myeloid Leukemia | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05194397) |
| November 19, 2021 | NCT05126849 | Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide in Patients With Acquired... | Assistance Publique - Hôpitaux de Paris | Phase 2 | Recruiting | Refractory Idiopathic Aplastic Anemia, Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation | 31 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05126849) |
| September 22, 2020 | NCT04558736 | Haploidentical HCT for Severe Aplastic Anemia | St. Jude Children's Research Hospital | Phase 2 | Recruiting | Aplastic Anemia, Bone Marrow Failure Syndrome | 21 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04558736) |
| April 22, 2020 | NCT04356469 | TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children | Johns Hopkins All Children's Hospital | Phase 2 | Recruiting | Hemoglobinopathy (Disorder), Severe Aplastic Anemia, Bone Marrow Failure Syndrome | 17 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04356469) |
| March 11, 2020 | NCT04304820 | Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA) | National Heart, Lung, and Blood Institute (NHLBI) | Phase 2 | Recruiting | Severe Aplastic Anemia | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04304820) |
| September 23, 2019 | NCT04099966 | AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion | Sponsor not shown (see the record) | Phase 2 | Recruiting | Acute Leukemia, Severe Aplastic Anemia, Non-hodgkin Lymphoma, Hodgkin Lymphoma, Kostmann, Diamond Blackfan Anemia... | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04099966) |
| July 9, 2018 | NCT03579875 | Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders | Masonic Cancer Center, University of Minnesota | Phase 2 | Recruiting | Fanconi Anemia, Severe Aplastic Anemia, Myelodysplastic Syndromes, T Cell Receptor Alpha/Beta Depletion, Telomere... | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03579875) |
| May 11, 2018 | NCT03520647 | Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant... | National Heart, Lung, and Blood Institute (NHLBI) | Phase 2 | Recruiting | Severe Aplastic Anemia (SAA), Hypo-Plastic Myelodysplastic Syndrome (MDS), Paroxysmal Nocturnal Hemoglobinuria (PNH) | 56 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03520647) |
| July 11, 2016 | NCT02828592 | Haploidentical Bone Marrow Transplant With Post-Transplant Cyclophosphamide for Patients With Severe Aplastic Anemia | Northside Hospital, Inc. | Phase 2 | Recruiting | Severe Aplastic Anemia | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02828592) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Institute of Hematology & Blood Diseases Hospital, China | 3 |
| National Heart, Lung, and Blood Institute (NHLBI) | 3 |
| Peking Union Medical College Hospital | 3 |
| Assistance Publique - Hôpitaux de Paris | 3 |
| Masonic Cancer Center, University of Minnesota | 2 |
| Hematology department of the 920th hospital | 2 |
| Cellenkos, Inc. | 1 |
| Medical College of Wisconsin | 1 |
| M.D. Anderson Cancer Center | 1 |
| Northside Hospital, Inc. | 1 |
| St. Jude Children's Research Hospital | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| The First Affiliated Hospital of Soochow University | 1 |
| Anhui Provincial Hospital | 1 |
| Children's Hospital of Philadelphia | 1 |
| Johns Hopkins All Children's Hospital | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 13 |
| China | 6 |
| France | 2 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Plumbers in the United States](https://specstream.ai/data/businesses/plumbers/united-states)
- [Criminal defense law firms in the United States](https://specstream.ai/data/businesses/criminal-defense-law-firms/united-states)
- [Road contractors in the United States](https://specstream.ai/data/businesses/road-contractors/united-states)
- [Energy companies in the United States](https://specstream.ai/data/businesses/energy-companies/united-states)
- [Surgery centers in the United States](https://specstream.ai/data/businesses/surgery-centers/united-states)
- [Gardening services in the United States](https://specstream.ai/data/businesses/gardening-services/united-states)
